The only FDA-approved treatments (disulfiram, naltrexone, and acamprosate) have been modestly successful in treating AUD (e.g., naltrexone reduces relapse rates by 5%) (for a detailed review and meta-analysis 1,2 ), but still are severely under-prescribed
n/a(n/a):e13929
The medication isnt wrong for you
they are not for human consumption, medical, diagnostic, cosmetic, veterinary, or any other non-research application
This is not always possible during high-intensity work, but during warm-ups, cooldowns, walking, and moderate-effort activities, consciously breathing through your nose preserves oral moisture
October 10, 2021